Master Bispecific Antibody Cell Line Development
Bispecific antibodies (bsAbs) are at the forefront of therapeutic innovation, offering the ability to target two antigens simultaneously, thereby revolutionizing treatment for diseases such as cancer and autoimmune disorders. Understanding the complexities of their development, especially in cell line engineering, is crucial for leveraging their full potential in biotherapeutics. Explore the latest advancements and strategies […]
4 minute read